NPM1 and acute myeloid leukemia: The notably aggressive clinical course observed in non-acute MNs with NPM1 mutation, leading to a frequent and rapid evolution to AML, highlights the necessity for a comprehensive diagnosis that incorporates both clinical and biological data.